PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Chronic Disease, Preventive Healthcare Market

July 5, 2018 12:26:29
  • Global preventive healthcare technologies and services market expected to reach $432 billion by 2024
  • Centers for Disease Control (CDC) states that seven out of 10 U.S. deaths are caused by chronic diseases such as diabetes, with global cost of treating diabetes reaching $776 billion within two decades
  • World Health Organization recommended in December 2017 that cannabidiol (CBD) should not be scheduled as a controlled substance, citing its potential as a beneficial pharmaceutical
  • PreveCeutical’s CBD-based Sol-gel delivery platform offers ease of application, better bioavailability and controlled cannabidiol release

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. In an exclusive interview with NetworkNewsAudio, PreveCeutical Chairman, CEO and President Stephen Van Deventer shared highlights of the company’s business model, products and R&D programs designed to provide next-generation preventative therapies ( Healthcare issues plaguing hundreds of millions of people around the world – namely diabetes, obesity, pain management, neurological disorders and cancers – are at the heart of PreveCeutical’s research program, he said.

A report by Grand View Research states that the global preventive healthcare technologies and services market is expected to reach $432 billion by 2024 ( Innovative, advanced technologies and development of preventive measures is seen as a driving force of the market. Underscoring the significance of this space is the…

Read More>>

More from NetworkNewsWire

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office